Flourescence in situ hybridization (FISH) screening for the 22q11.2 deletion in patients with clinical features of velocardiofacial syndrome but without cardiac anomalies

Genetics and Molecular Biology

Volumn 30, Issue 1, 2007, Pages 21-24

  Sandrin Garcia, Paula ^a   Richieri Costa, Antonia ^a   Tajara, Eloiza Helena ^b   Carvalho Salles, Andréa Borduchi ^b   Fett Conte, Agnes Cristina ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FACULDADE DE MEDICINA DE SÃO JOSÉ DO RIO PRETO   (Brazil)

Author keywords

22q11.2 deletion; Velocardiofacial syndrome

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CHROMOSOME 22Q; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; DISEASE ASSOCIATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FREQUENCY ANALYSIS; GENE FREQUENCY; GENE PROBE; GENETIC ASSOCIATION; GENETIC SCREENING; HETEROZYGOTE; HUMAN; LABORATORY TEST; MALE; PSYCHOLOGIC ASSESSMENT; VELOCARDIOFACIAL SYNDROME;

EID: 34247098816     PISSN: 14154757     EISSN: 16784685     Source Type: Journal    
DOI: 10.1590/S1415-47572007000100006     Document Type: Article

References (20)

1. Adeyinka A, Stockero KJ, Flynn HC, Lorentz CP, Ketterling RP and Jalal SM (2004) Familial 22q11.2 deletions in DiGeorge/velocardiofacial syndrome are predominantly smaller than the commonly observed 3 Mb. Genet Med 6:517-520.
2. Bassett AS, Chow EWC, Husted J, Weksberg R, Caluseriu O, Webb GD and Gatzoulis M (2005) Clinical features of 78 adults with 22q11 deletion syndrome. Am J Med Genet 138:307-313.
3. Carlson C, Papolos, D, Pandita RK, Faeda GL, Veit S, Goldberg R, Shprintzen RJ, Kucherlapati R and Morrow BE (1997a) Molecular analysis of velo-cardio-facial syndrome patients with psychiatric disorders. Am J Hum Genet 60:851-859.
4. Carlson C, Sirotikin H, Pandita R, Goldberg R, Mckie J, Wadey R, Pantajali SR, Weissman SM, Anyane-Yeboa K, Warburton D, Scambler P, Shprintzen RJ, Kucherlapati R and Morrow BE (1997b) Molecular definition of 22q11 deletions in 151 velo-cardio-facial syndrome patients. Am J Hum Genet 61:620-629.
5. Devriendt K, Fryns JP, Mortier G, Van Thienen MN and Key-molen K (1998) The annual incidence of DiGeorge/velocardiofacial syndrome. J Med Genet 35:789-790.
6. Digilio MC, Angioni A, De Santis M, Lombardo A, Gianotti A, Dallapiccola B and Marino B (2003) Spectrum of clinical variability in familial deletion 22q11.2 from full manifestation to extremely mild clinical anomalies. Clin Genet 63:308-313.
7. Driscoll DA, Spinner NB, Budarf ML, McDonald-McGinn DM, Zackai EH, Goldberg RB, Shprintzen RJ, Saal HM, Zonana J, Jones MC, Mascarello JT and Emanuel BS (1992) Deletions and microdeletions of 22q11.2 in velo-cardio-facial syndrome. Am J Med Genet 44:261-268.
8. Edelman L, Pandita RK and Morrow BE (1999) Low-copy repeats mediate the common 3 Mb deletion in patients with velocardiofacial syndrome. Am J Hum Genet 60:1076-1086.
9. Kitsiou-Tzeli S, Kolialexi A, Fryssira H, Galla-Voumvouraki A, Salavoura K, Kanariou M, Tsangaris GT, Kanavakis E and Mavrou A (2004) Detection of 22q11.2 deletion among 139 patients with Di George/velocardiofacial syndrome features. In Vivo 18:603-608.
10. Lindsay EA, Greenberg F, Shaffer LG, Shapira SK, Scambler PJ and Baldini A (1995a) Submicroscopic deletions at 22q11.2: Variability of the clinical picture and delineation of a commonly deleted region. Am J Med Genet 56:191-197.
11. Lindsay E, Goldberg R, Jurecic V, Morrow B, Carlson C, Kucherlapati RS, Sbprintzen RJ and Baldini A (1995b) Velo-cardio-facial syndrome: Frequency and extent of 22q11 deletions. Am J Med Genet 57:514-522.
12. Lipson HA, Yuille D, Angel M, Thompson PG, Vandervood JG and Beckenham EJ (1991) Velocardiofacial (Shprintzen) syndrome: An important syndrome for the dysmorphologist to recognize. J Med Genet 28:596-604.
13. McDonald-McGinn DM, Kirschner R, Goldmuntz E, Eicher P, Gerdes M, Moss E, Solot C, Wang P, Jacobs I, Handler S, Knightly C, Heber K, Wilson M, Ming JE, Grace K, Driscole D, Pasquariello P, Randall P, Larossa D, Emanuel BS and Zackai EH (1999) The Philadelphia story: The 22q11.2 deletion: Report on 250 patients. Genet Couns 10: 11-24.
14. Morrow B, Goldberg R, Carlson C, Gupta RD, Sirotkin H, Collins J, Dunham I, O'Donnel H, Scambler P, Shprintzen R and Kucherlapati R (1995) Molecular definition of the 22q11 deletions in velo-cardio-facial syndrome. Am J Hum Genet 56:1391-1403.
15. Ryan AK, Goodship JA, Wilson DI, Philip N, Levy A, Seidel H, Schuffenhauer S, Oechsler H, Belohradsky B, Prieur M, Aurias A, Raymond FL, Clayton-Smith J, Hatchwell E, McKeown C, Beemer FA, Dallapiccola B, Novelli G, Hurst JA, Ignatius J, Green AJ, Winter RM, Brueton L, Brondum-Nielsen K and Scambler PJ (1997) Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: A European collaborative study. J Med Genet 34:798-804.
16. Sandrin-Garcia P, Macedo C, Martelli LR, Ramos ES, Guion-Almeida ML, Richeri-Costa A and Passos GAS (2002) Recurrent 22q11.2 deletion in a sibship suggestive of parental germline mosaicism in velocardiofacial syndrome. Clin Genet 61:380-383.
17. Scambler PJ (2000) The 22q11 deletion syndromes. Hum mol Genet 9:2421-2426.
18. Shprintzen RJ (1990) Velo-cardio-facial syndrome. In: Buyse ML (ed) Birth Defects Encyclopedia. Center of Birth Defects Information Services, Dover, pp 1744-1745.
19. Shprintzen RJ, Goldberg R, Young D and Wolford L (1981) The velocardiofacial syndrome: A clinical and genetics analysis. Pediatr 67:167-172.
20. Yunis J (1976) High resolution of human chromosomes. Science 191:1268-1270.